FindTrial
Sign In

Quantitative Analysis of Serum IgG Galactosylation Assists to Predict Postoperative Recurrence of Atrial Fibrillation

Quantitative Analysis of Serum IgG Galactosylation Assists to Predict Postoperative Recurrence of Atrial Fibrillation

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000034610
Enrollment
Unknown
Registered
2020-07-12
Start date
2020-07-17
Completion date
Unknown
Last updated
2020-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial fibrillation

Interventions

Gold Standard:Clinical outcome
Index test:Quantitative&#32
Analysis&#32
of&#32
Serum&#32
IgG&#32
Galactosylation&#32
Assists

Sponsors

Affiliated Hospital of Nantong University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with atrial fibrillation; 2. Treatment with circular pulmonary vein electrical isolation; 3. Patient must sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Women who are not menopausal; 2. Patients with immune diseases; 3. Patients diagnosed with malignant tumors; 4. Renal insufficiency; 5. BMI > 23; 6. Diabetics.

Design outcomes

Primary

MeasureTime frame
Electrocardiogram;Ambulatory electrocardiogram;Galactosylation level;SEN, SPE, ACC, AUC of ROC;—

Secondary

MeasureTime frame
Left Atrial Volume Index;—

Countries

China

Contacts

Public ContactLu Qi

Affiliated Hospital of Nantong University

luqint@sina.com+86 13962989292

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026